Clinical Trials Browser

Phase 1 × Breast Neoplasms × tomivosertib × Clear all

NCT04261218 2022-07-20

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer

Phase 1 Completed

Breast Neoplasms